Title : Proangiogenic tumor proteins as potential predictive or prognostic biomarkers for bevacizumab therapy in metastatic colorectal cancer.

Pub. Date : 2014 Aug 1

PMID : 24374727






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 "Low" tumor VEGF-A level was predictive of better ORR for bevacizumab [ORR (low) 53% vs. (high) 19%, interaction p = 0.03] but not for PFS [hazard ratio, HR (low) 0.73 vs. (high) 0.62, interaction p = 0.68] in the comparison of capecitabine (C) versus C and bevacizumab (CB) and CB plus mitomycin (M). Capecitabine vascular endothelial growth factor A Homo sapiens